Related references
Note: Only part of the references are listed.Increased thrombospondin-2 in human fibrosclerotic and stenotic aortic valves
Virva Pohjolainen et al.
ATHEROSCLEROSIS (2012)
Thrombospondin-2 prevents cardiac injury and dysfunction in viral myocarditis through the activation of regulatory T-cells
Anna-Pia Papageorgiou et al.
CARDIOVASCULAR RESEARCH (2012)
A Thrombospondin-Dependent Pathway for a Protective ER Stress Response
Jeffrey M. Lynch et al.
CELL (2012)
Thrombospondin-4 regulates fibrosis and remodeling of the myocardium in response to pressure overload
Ella G. Frolova et al.
FASEB JOURNAL (2012)
Thrombospondins in physiology and disease: New tricks for old dogs
Joanne E. Murphy-Ullrich et al.
MATRIX BIOLOGY (2012)
The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47
David D. Roberts et al.
MATRIX BIOLOGY (2012)
Adhesion-modulating/matricellular ECM protein families: A structural, functional and evolutionary appraisal
Deane F. Mosher et al.
MATRIX BIOLOGY (2012)
MATRICELLULAR PROTEINS IN CARDIAC ADAPTATION AND DISEASE
Nikolaos G. Frangogiannis
PHYSIOLOGICAL REVIEWS (2012)
MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure
Geert C. van Almen et al.
AGING CELL (2011)
Thrombospondin-4 Is Required for Stretch-Mediated Contractility Augmentation in Cardiac Muscle
Oscar H. Cingolani et al.
CIRCULATION RESEARCH (2011)
Therapies using anti-angiogenic peptide mimetics of thrombospondin-1
Jack Henkin et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Endogenous Thrombospondin 1 Protects the Pressure-Overloaded Myocardium by Modulating Fibroblast Phenotype and Matrix Metabolism
Ying Xia et al.
HYPERTENSION (2011)
Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy
Geert C. van Almen et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Metabolic characterization of volume overload heart failure due to aorto-caval fistula in rats
Vojtech Melenovsky et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Progress and challenges in translating the biology of atherosclerosis
Peter Libby et al.
NATURE (2011)
Thrombospondin-4 polymorphism (A387P) predicts cardiovascular risk in postinfarction patients with high HDL cholesterol and C-reactive protein levels
James P. Corsetti et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Metoprolol Treatment Lowers Thrombospondin-4 Expression in Rats with Myocardial Infarction and Left Ventricular Hypertrophy
Erja Mustonen et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2010)
Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation
Eileen M. Bauer et al.
CARDIOVASCULAR RESEARCH (2010)
Thrombospondin-4 Regulates Vascular Inflammation and Atherogenesis
Ella G. Frolova et al.
CIRCULATION RESEARCH (2010)
Contribution of extracellular matrix to the mechanical properties of the heart
Gregory M. Fomovsky et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction
Marcin Dobaczewski et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Molecular targets and regulators of cardiac hypertrophy
Rohini Agrawal et al.
PHARMACOLOGICAL RESEARCH (2010)
Cellular preservation therapy in acute myocardial infarction
Antonio Abbate et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Autophagy in the cardiovascular system
Guido R. Y. De Meyer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Decreased frequency of the 3′UTR T>G single nucleotide polymorphism of thrombospondin-2 gene in sudden death due to plaque erosion
Allen Burke et al.
CARDIOVASCULAR PATHOLOGY (2009)
Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling
Gerald W. Dorn
CARDIOVASCULAR RESEARCH (2009)
Absence of Thrombospondin-2 Causes Age-Related Dilated Cardiomyopathy
Melissa Swinnen et al.
CIRCULATION (2009)
Global deletion of thrombospondin-1 increases cardiac and skeletal muscle capillarity and exercise capacity in mice
Moh H. Malek et al.
EXPERIMENTAL PHYSIOLOGY (2009)
Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload
Ying Xia et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2009)
Differential Interactions of Thrombospondin-1,-2, and-4 with CD47 and Effects on cGMP Signaling and Ischemic Injury Responses
Jeff S. Isenberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Hypertension and heart failure: a dysfunction of systole, diastole or both?
G. W. Yip et al.
JOURNAL OF HUMAN HYPERTENSION (2009)
Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress
Jeff S. Isenberg et al.
MATRIX BIOLOGY (2009)
Decreased Expression of Thrombospondin-1 in Failing Hearts May Favor Ventricular Remodeling
M. Batlle et al.
TRANSPLANTATION PROCEEDINGS (2009)
Thrombospondins function as regulators of angiogenesis
Paul Bornstein
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2009)
Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies
Jeff S. Isenberg et al.
NATURE REVIEWS CANCER (2009)
Thrombospondin-2 modulates extracellular matrix remodeling during physiological angiogenesis
Marie M. Krady et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Cd47: A new target in cardiovascular therapy
Jeff S. Isenberg et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Thrombospondin-4 expression is rapidly upregulated by cardiac overload
Erja Mustonen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Cardiomyocyte death and renewal in the normal and diseased heart
Louis Maximilian Buja et al.
CARDIOVASCULAR PATHOLOGY (2008)
Structure of thrombospondins
C. B. Carlson et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Thrombospondin-1 Deficiency Accelerates Atherosclerotic Plaque Maturation in ApoE-/- Mice
Rute Moura et al.
CIRCULATION RESEARCH (2008)
Thrombospondin and Apoptosis: Molecular Mechanisms and Use for Design of Complementation Treatments
Y. Mirochnik et al.
CURRENT DRUG TARGETS (2008)
Enhancing Cardiovascular Dynamics by Inhibition of Thrombospondin-1/CD47 Signaling
Jeff S. Isenberg et al.
CURRENT DRUG TARGETS (2008)
Polymorphisms in thrombospondin genes and myocardial infarction:: a case-control study and a meta-analysis of available evidence
Werner Koch et al.
HUMAN MOLECULAR GENETICS (2008)
Antiangiogenic treatment prevents adventitial constrictive remodeling in graft arteriosclerosis
Olivier Thaunat et al.
TRANSPLANTATION (2008)
Blocking Thrombospondin-1/CD47 signaling alleviates deleterious effects of aging on tissue responses to ischemia
Jeff S. Isenberg et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
A thrombospondin-1 antagonist of transforming growth factor-β activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II
Souad Belmadani et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Interactions between CD47 and thrombospondin reduce inflammation
Laurence Lamy et al.
JOURNAL OF IMMUNOLOGY (2007)
Decompensation of cardiac hypertrophy: Cellular mechanisms and novel therapeutic targets
Abhinav Diwan et al.
PHYSIOLOGY (2007)
Thrombospondin-based antiangiogenic therapy
Xuefeng Zhang et al.
MICROVASCULAR RESEARCH (2007)
Systolic and diastolic heart failure: Differences and similarities
Kanu Chatterjee et al.
JOURNAL OF CARDIAC FAILURE (2007)
How do cardiomyocytes die? - Apoptosis and autophagic cell death in cardiac myocytes
Sanjay Kunapuli et al.
JOURNAL OF CARDIAC FAILURE (2006)
Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts
NG Frangogiannis et al.
CIRCULATION (2005)
Distinct upregulation of extracellular matrix genes in transition from hypertrophy to hypertensive heart failure
J Rysä et al.
HYPERTENSION (2005)
Cardiac remodeling and failure - From molecules to man (Part 1)
PWM Fedak et al.
CARDIOVASCULAR PATHOLOGY (2005)
Thrombospondin-2 is essential for myocardial matrix integrity - Increased expression identifies failure-prone cardiac hypertrophy
B Schroen et al.
CIRCULATION RESEARCH (2004)
Tumor progression: the effects of thrombospondin-1 and-2
J Lawler et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Ventricular remodeling after infarction and the extracellular collagen matrix - When is enough enough?
BI Jugdutt
CIRCULATION (2003)
Increased expression of thrombospondin-1 in vessel wall of diabetic Zucker rat
OI Stenina et al.
CIRCULATION (2003)
The role of myocardial fibrillar collagen in ventricular remodeling and function
JS Janicki et al.
JOURNAL OF CARDIAC FAILURE (2002)
Molecular mechanisms involved in atherosclerosis
M Soufi et al.
HERZ (2002)
Load-dependent and -independent regulation of proinflammatory cytokine and cytokine receptor gene expression in the adult mammalian heart
G Baumgarten et al.
CIRCULATION (2002)
Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction
EJ Topol et al.
CIRCULATION (2001)
Thrombospondins as matricellular modulators of cell function
P Bornstein
JOURNAL OF CLINICAL INVESTIGATION (2001)
Cartilage oligomeric matrix protein (thrombospondin-5) is expressed by human vascular smooth muscle cells
R Riessen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Left ventricular remodeling after myocardial infarction - Pathophysiology and therapy
MGS Sutton et al.
CIRCULATION (2000)
Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling
YY Li et al.
CARDIOVASCULAR RESEARCH (2000)
Share Paper
